HER3

May 7, 2018May 7, 2018

Possible Reasons Why Tyverb/Tykerb Fails as Breast Cancer Monotherapy Explored in Study

News

Lapatinib, an approved medicine for advanced breast cancer available under the brand names Tyverb in Europe and Tykerb in the U.S., can sometimes cause breast cancer cells to grow under ... Read more

February 1, 2018

Patient Dosing Begins in Phase 2 Trial of MCLA-128 in Metastatic Breast Cancer

News

The first patient in the Phase 2 clinical study of MCLA-128 in metastatic breast cancer patients has been dosed, The Netherlands-based immuno-oncology company Merus recently announced. The international study (NCT03321981) ... Read more

July 13, 2016October 18, 2016

New Imaging Technique Could Lead to Better-Targeted Breast Cancer Treatment

News

Scientists with Cancer Research UK at Kings College London have developed new imaging techniques that can identify with greater accuracy breast cancer patients that might respond to human epidermal growth ... Read more